Natixis
- SEC CIK
- 0001274981
- Latest filing
- Aug 13, 2026
CRL holding history
Charles River Laboratories International, Inc. in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRL overviewAll 13F holders of CRLFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −14,010−100.0% | Sold out | Holders |
| Q3 2025 | 14,010 | $2.19M | <0.1% | +7,058+101.5% | Added | Holders |
| Q2 2025 | 6,952 | $1.05M | <0.1% | +3,980+133.9% | Added | Holders |
| Q1 2025 | 2,972 | $444.0K | <0.1% | +2,972 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −3,473−100.0% | Sold out | Holders |
| Q3 2024 | 3,473 | $684.1K | <0.1% | −268−7.2% | Reduced | Holders |
| Q2 2024 | 3,741 | $772.8K | <0.1% | −164−4.2% | Reduced | Holders |
| Q1 2024 | 3,905 | $1.06M | <0.1% | +3,905 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −4,722−100.0% | Sold out | Holders |
| Q1 2023 | 4,722 | $953.0K | <0.1% | +4,722 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −30,625−100.0% | Sold out | Holders |
| Q3 2022 | 30,625 | $6.03M | <0.1% | +27,800+984.1% | Added | Holders |
| Q2 2022 | 2,825 | $605.0K | <0.1% | −42,789−93.8% | Reduced | Holders |
| Q1 2022 | 45,614 | $13.0M | <0.1% | +30,439+200.6% | Added | Holders |
| Q4 2021 | 15,175 | $5.72M | <0.1% | +2,562+20.3% | Added | Holders |
| Q3 2021 | 12,613 | $5.21M | <0.1% | +6,633+110.9% | Added | Holders |
| Q2 2021 | 5,980 | $2.21M | <0.1% | +5,980 | New | Holders |